Back to Search Start Over

Additional file 1 of Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

Authors :
Heffler, Enrico
Saccheri, Fabiana
Bartezaghi, Marta
Canonica, Giorgio Walter
Publication Year :
2020
Publisher :
figshare, 2020.

Abstract

Additional file 1: Figure S1. Efficacy comparison of outcome parameters at baseline and 12 months after omalizumab treatment in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) compared with chronic sinusitis/rhinosinusutis without (CRSsNP). (A) Mean Asthma Control Questionnaire scores, and the change from baseline in ACQ score; (B) Median percent predicted forced expiratory volume in 1 s (FEV1), and change from baseline in percent predicted FEV1; (C) Median number of annual exacerbations in the year prior to initiating omalizumab treatment (baseline) and during 12 months’ treatment with omalizumab, and change from baseline. The p-values within cohorts were calculated using a signed rank test and p-values for comparisons between cohorts were calculated using an ANCOVA model on ranks.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....65f58ba9090320259fb7980b3de7195c
Full Text :
https://doi.org/10.6084/m9.figshare.12569012.v1